10x Genomics, Inc. TXG Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s accumulated depreciation?
- 10x Genomics, Inc. (TXG) reported accumulated depreciation of $160.95M in Q1 2026.
- How has 10x Genomics, Inc.'s accumulated depreciation changed year-over-year?
- 10x Genomics, Inc.'s accumulated depreciation increased by 22.8% year-over-year, from $131.11M to $160.95M.
- What is the long-term trend for 10x Genomics, Inc.'s accumulated depreciation?
- Over 4 years (2020 to 2025), 10x Genomics, Inc.'s accumulated depreciation has grown at a 49.8% compound annual growth rate (CAGR), from $30.5M to $153.46M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.